MYLAN 531 (Sulindac 200 mg)
Pill imprint MYLAN 531 has been identified as Sulindac 200 mg.
Sulindac is used in the treatment of pain; ankylosing spondylitis; osteoarthritis; gout, acute; bursitis (and more), and belongs to the drug class nonsteroidal anti-inflammatory agents. Risk cannot be ruled out during pregnancy. Sulindac 200 mg is not a controlled substance under the Controlled Substance Act (CSA).
- MYLAN 531
- 200 mg
- 11.00 mm
- Prescription only
- Drug Class:
- Nonsteroidal anti-inflammatory agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
sodium lauryl sulfate
|NDC Code||Manufacturer / Repackager|
|51079-0667||UDL Laboratories Inc|
|54569-4032||A-S Medication Solutions, LLC (repackager)|
Note: Inactive ingredients may vary.
More about sulindac
- Other brands: Clinoril
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.